ABSTRACT. Adult HBV-transgenic males produce more hepatitis B surface antigen (HBsAg) in serum than females. The difference decreases with castration and is restored with testosterone replacement. T o investigate the contribution of the androgen receptor in this process, IIBVtransgenic males were mated with females heterozygous for the testicular feminization mutation (Tfm), an S-linked gene with 90% reduced androgen receptor. A total of 19 phenotypic HBV-transgenic females were studied, of which eight SF" females were identified by the presence of Ychromosome DNA using molecular hybridization. The 11 normal ( S S ) females had 11.7 f 3.5 pg/mL (mean f S D ) of HBsAg in their serum, whereas the Tfm (SY) females had 17.1 f 5.9 pg/mL ( p < 0.05). However, the Tfm (SY) females produced less HBsAg than 33 normal (SY) males (41 f 12 pg/mL), and the overall ratio of male/female HBsAg levels was reduced: S Y / S S = 3 versus SY'""/SS Chronic camers are at a n increased risk for cirrhosis and hepatocellular carcinoma (2) . In particular, male chronic camers of HBV have a 3-to ten-fold increased incidence of hepatocellular carcinoma compared with female chronic camers (3). than female transgenic mice (5-7). The castration of male transg e n i c~ resulted in the lowering of the HBsAg concentration (5, 8) . Thus, it appears that testosterone is responsible at least partially for the increased HBV levels seen in males.
Testosterone may increase the HBsAg concentration through its action on the androgen receptor. T o test this hypothesis, we have used the following rationale. We compared the surface antigen levels of transgenic X Y mice without functioning androgen receptors to the levels in female mice. If the androgen receptor-androgen complex is responsible for the increased levels in males, male transgenic mice lacking androgen receptors should have a similar surface antigen concentration as d o females.
There is a well-known strain of mice that contains an X-linked mutation causing the absence ofthe androgen receptor in affectcd mice (9, 10) . This defect is analogous to the testicular feminization syndrome in humans. All known androgen target cells. embryonic Wolffian ducts and urogenital sinus, hypothalamicpituitary axis, proximal kidney tubules, and submaxillary glands in this Tfm mouse are insensitive to testosterone (10) (11) (12) . Glucocorticoids also have been described to stimulate the expression of HBsAg (5, 8) .
MATERIALS A N D METHODS
Animals. The G26 HBV transgenic mouse line used in this study has been described previously (6) . Female mice heterozygous for the testicular feminization gene were obtained from Jackson Laboratories (Bar Harbor, ME).
For the glucocorticoid experiments, all animals were bled before injection, injected with dexamethasone (0.1 m L Hexadrol phosphate [20 mg/mL], Organon, Inc., West Orange, NJ) and bled at d 0, 3, 6, and 10. In a n equal number of mice who were untreated, HBsAg level variability was measured on d 0, 3, 6, and 10.
For the testosterone experiments, animals received testosterone enanthate 20 mg intraperitoneally (Gynex, Vernon Hills, IL), and they were bled on d 0 and 3.
Clittical chetnistry. Serum HBsAg levels were determined using the AUSRIA I1 solid phase RIA kit (Abbott Laboratories, North Chicago, IL). The levels were quantified by comparison to a standard curve generated from a purified sample of HBsAg 40 pg/mL (provided by Merck Sharp & Dohme Research Laboratory, West Point, PA) serially diluted in human serum that was negative for HBsAg and anti-HBsAg. Transgenic mouse sera to be quantified were diluted 500-fold to be in the linear portion of the curve. Curve fitting and interpolation were done using the four-parameter logistic function as described (1 3).
The interassay coefficient of variation and the intraassay coefficient of variation were < 10%.
DNA ana1pi.y. T o determine the presence of a Y chromosome.
DNA was extracted from tail segments and assayed by Southern analysis for the presence of Y chromosomal DNA. Five pg of DNA were digested with EcoRI, electrophoresed through a 0.8% agarose gel, blotted, and hybridized with a Y-chromosome DNA probe. The Y-chromosome probe was kindly provided by Dr. E. Palmer (14) . The cloned inset Y-chromosome DNA fragment was gel purified from the pY 1 plasmid and labeled to high specific activity (>I x 108 cpm/pg) random primer extension (15 
RESULTS
T o generate HBV transgenic mice that lack the androgen receptor, we crossed G26 males homozygous for the HBV transgene with female mice carrying the Tfm mutation. Twenty progeny were produced. Nineteen were phenotypic females, one was a phenotypic male. All progeny were heterozygous for the hepatitis B transgene. In addition, the resultant progeny were XY males, males that contained the Tfm mutation and appear phenotypically female, or X X females, some of which carry the Tfm mutation. Thus, of the phenotypic females, mice with a Y chromosome lack the androgen receptor. T o distinguish genotypic male mice containing the Tfm mutation from X X female mice, we probed all the phenotypic females for Y-chromosome DNA by Southern blot hybridization using a mouse Y-chromosome DNA probe specific for the mouse Y chromosome (Fig.  1) . Lanes 1 through 3 demonstrate the presence of Y-chromosome DNA fragments to be 2.2 and 2.0 kb in size. Therefore, the phenotypic females containing Y-chromosome DNA are Tfm mice. Lanes 4 through 6, 8, and 9 were from normal XX female mice and thus d o not hybridize with the Y-chromosome probe. In total, the FIG26 homozygous XTrm heterozygous cross produced 11 X X females, eight XY females, and one XY male. For unknown reasons, additional crosses with the XXTrm females failed to yield more XY transgenic males. We have, therefore, included HBsAg levels of 32 additional XY transgenics from previous experiments.
The HBsAg levels in the 52 mice tiom the transgenic cross were determined on samples obtained at approximately 6 m o of age (Fig. 2) . The male mice produced substantially more serum HBsAg (41 + 12 pg/mL; range, 25-55) than did the female mice 
DISCUSSION
Male transgenic mice produce higher serum HBsAg levels than female transgenic mice (5-7). Female transgenic mice given testosterone increase their levels of HBsAg, but not to male levels (5, 8) . The male-female difference has been attributed to the greater amount of testosterone in males, and the male-testosterone supplement and female difference have been attributed to the different amount of liver androgen receptors in male and female mice (8) .
We found that the male-female serum HBsAg level difference is due, at least in part, to the presence of androgen receptors. The male mouse had more serum HBsAg than did the female mice, and the male to female HBsAg ratio was substantially greater than the XTfmY to XX HBsAg ratio. It is surprising there is a difference between the serum HBsAg levels in XX female and XTimY female mice. This difference is probably not due to a n inhibitory modulation by estrogen in XX female mice because estrogen also has been shown to stimulate HBsAg production in transgenic mice (5) . The difference is probably not due to aromatization of androgens causing increased estrogen levels because testicular feminized mice produce only one third of the normal amount of testosterone after puberty ( 16) .
Conversely, glucocorticoids stimulated the expression of HBsAg gene markedly in a time-dependent fashion. Because the stimulation was nearly identical in XX and XTimY mice, we conclude that the effect of glucocorticoids on HBsAg levels is not mediated by the androgen receptor. This is in agreement with data published by Farza 6.t al. (5) .
T o be certain that the androgen effect demonstrated in this study is indeed mediated via the androgen receptor, we treated XX female mice and Tfm mice with testosterone enanthate. The rise in HBsAg after testosterone was significant in female mice and negligible in Tfm mice. The rise in XX female mice was of similar magnitude as reported by Farza ct a/. (5) in castrated female transgenic mice.
Based on these results, we can speculate that the difference In HBsAg protein expression between XY mice lacking the androgen rcccptor and XX mice may be due to nonandrogcnic causcs of sexual dimorphism determining levels of expression of the HBsAg gene.
